{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:08:45Z","timestamp":1790780925369,"version":"4.1.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T00:00:00Z","timestamp":1521331200000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["CBET0954957"],"award-info":[{"award-number":["CBET0954957"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01EY024072"],"award-info":[{"award-number":["R01EY024072"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jconrel.2017.02.023","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T11:01:48Z","timestamp":1487761308000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Folate-mediated chemotherapy and diagnostics: An updated review and outlook"],"prefix":"10.1016","volume":"252","author":[{"given":"Leyuan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianming","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2017.02.023_bb0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jn\/130.2.129","article-title":"Folate and carcinogenesis: an integrated scheme","volume":"130","author":"Choi","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0010","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood.V79.11.2807.2807","article-title":"The biological chemistry of folate receptors","volume":"79","author":"Antony","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0015","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1017\/S1462399409000969","article-title":"Membrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissues","volume":"11","author":"Zhao","year":"2009","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0025","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0030","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications","volume":"73","author":"Ross","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0035","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/0006-2952(93)90235-O","article-title":"Altered folate-binding protein mRNA stability in KB cells grown in folate-deficient medium","volume":"45","author":"Hsueh","year":"1993","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0040","doi-asserted-by":"crossref","first-page":"25539","DOI":"10.1016\/S0021-9258(19)78324-0","article-title":"Evidence that a specific interaction between an 18-base cis-element in the 5\u2032-untranslated region of human folate receptor-alpha mRNA and a 46-kDa cytosolic trans-factor is critical for translation","volume":"271","author":"Sun","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0045","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.addr.2004.01.001","article-title":"Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy","volume":"56","author":"Elnakat","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21712","article-title":"The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander?","volume":"119","author":"Kelemen","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F","article-title":"Overexpression of folate binding protein in ovarian cancers","volume":"74","author":"Toffoli","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0060","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1016\/j.biomaterials.2013.05.071","article-title":"IR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapy","volume":"34","author":"Yue","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/mp070049c","article-title":"Preclinical antitumor activity of a novel folate-targeted dual drug conjugate","volume":"4","author":"Leamon","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10637-014-0171-9","article-title":"A phase I pharmacokinetic and safety analysis of epothilone folate (BMS-753493), a folate receptor targeted chemotherapeutic agent in humans with advanced solid tumors","volume":"33","author":"Peethambaram","year":"2015","journal-title":"Investig. New Drugs"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0075","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","article-title":"Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments","volume":"26","author":"Ledermann","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0080","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.addr.2004.01.003","article-title":"Antifolates targeted specifically to the folate receptor","volume":"56","author":"Jackman","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0085","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.addr.2004.01.008","article-title":"Folate-targeted chemotherapy","volume":"56","author":"Leamon","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0090","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.addr.2004.02.003","article-title":"Folate receptor-targeted drugs for cancer and inflammatory diseases","volume":"56","author":"Low","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0095","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.addr.2004.01.009","article-title":"Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential","volume":"56","author":"Lu","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0168-3659(03)00215-3","article-title":"Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects","volume":"91","author":"Lu","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0105","first-page":"3281","article-title":"Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy","volume":"7","author":"Wang","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0110","first-page":"739","article-title":"Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft","volume":"7","author":"Chaudhury","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0115","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1007\/s11095-010-0196-5","article-title":"Paclitaxel-loaded, folic-acid-targeted and TAT-peptide-conjugated polymeric liposomes: in vitro and in vivo evaluation","volume":"27","author":"Zhao","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0120","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/CAD.0000000000000047","article-title":"Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3\/TAX ovarian cancer cells","volume":"25","author":"Tong","year":"2014","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0125","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2016.04.015","article-title":"Magnetically and pH dual responsive dendrosomes for tumor accumulation enhanced folate-targeted hybrid drug delivery","volume":"232","author":"Wang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0130","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1021\/nn900649v","article-title":"HFT-T, a targeting nanoparticle, enhances specific delivery of paclitaxel to folate receptor-positive tumors","volume":"3","author":"Wang","year":"2009","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0135","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.1021\/nn200739q","article-title":"A folate receptor-targeting nanoparticle minimizes drug resistance in a human cancer model","volume":"5","author":"Wang","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0140","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.biomaterials.2009.11.106","article-title":"The therapeutic efficiency of FP-PEA\/TAM67 gene complexes via folate receptor-mediated endocytosis in a xenograft mice model","volume":"31","author":"Arote","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejps.2013.10.011","article-title":"Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy","volume":"52","author":"Li","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0150","first-page":"1489","article-title":"Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer","volume":"8","author":"Kim","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0155","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.2147\/IJN.S42440","article-title":"Low-weight polyethylenimine cross-linked 2-hydroxypopyl-beta-cyclodextrin and folic acid as an efficient and nontoxic siRNA carrier for gene silencing and tumor inhibition by VEGF siRNA","volume":"8","author":"Li","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0160","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.biomaterials.2012.09.039","article-title":"PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor","volume":"34","author":"Shi","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0165","doi-asserted-by":"crossref","first-page":"8990","DOI":"10.1021\/nn203165z","article-title":"Folate-targeted polymeric nanoparticle formulation of docetaxel is an effective molecularly targeted radiosensitizer with efficacy dependent on the timing of radiotherapy","volume":"5","author":"Werner","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2013.08.071","article-title":"Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery","volume":"456","author":"Qiu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0175","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.2147\/IJN.S32620","article-title":"Antitumor activity of folate-targeted, paclitaxel-loaded polymeric micelles on a human esophageal EC9706 cancer cell line","volume":"7","author":"Wu","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0180","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1021\/mp3002914","article-title":"Biological characterization of folate-decorated biodegradable polymer-platinum(II) complex micelles","volume":"9","author":"Wang","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0185","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2016.02.025","article-title":"A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation","volume":"226","author":"Chen","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2016.07.002","article-title":"Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo","volume":"104","author":"Dai","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0195","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1039\/C6BM00376A","article-title":"Liquid crystalline nanoparticles encapsulating cisplatin and docetaxel combination for targeted therapy of breast cancer","volume":"4","author":"Thapa","year":"2016","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0200","doi-asserted-by":"crossref","first-page":"27669","DOI":"10.1038\/srep27669","article-title":"Utilizing G2\/M retention effect to enhance tumor accumulation of active targeting nanoparticles","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0205","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1039\/C5NR07348K","article-title":"In situ crosslinked smart polypeptide nanoparticles for multistage responsive tumor-targeted drug delivery","volume":"8","author":"Yi","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0210","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1007\/s12272-014-0489-z","article-title":"Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting","volume":"37","author":"Lee","year":"2014","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0215","doi-asserted-by":"crossref","first-page":"10120","DOI":"10.1016\/j.biomaterials.2013.09.006","article-title":"A pH-sensitive gene delivery system based on folic acid-PEG-chitosan - PAMAM-plasmid DNA complexes for cancer cell targeting","volume":"34","author":"Wang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0220","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.biomaterials.2012.12.004","article-title":"Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA","volume":"34","author":"Kim","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0225","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1039\/c3ob40969d","article-title":"Disulfide bond reduction-triggered molecular hydrogels of folic acid-Taxol conjugates","volume":"11","author":"Yang","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0230","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bmc.2012.10.044","article-title":"Synthesis and biological evaluation of a folate-targeted rhaponticin conjugate","volume":"21","author":"Liang","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0235","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/srep01104","article-title":"Potential use of folate-appended methyl-beta-cyclodextrin as an anticancer agent","volume":"3","author":"Onodera","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0240","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1016\/j.biomaterials.2013.03.017","article-title":"Cucumber mosaic virus as drug delivery vehicle for doxorubicin","volume":"34","author":"Zeng","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0245","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1016\/j.biomaterials.2013.09.007","article-title":"Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model","volume":"34","author":"Shao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0250","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1016\/j.biomaterials.2011.04.006","article-title":"Folate-decorated nanogels for targeted therapy of ovarian cancer","volume":"32","author":"Nukolova","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0255","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1039\/c2nr12094a","article-title":"Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects","volume":"4","author":"Gao","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0260","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2012.03.003","article-title":"Ligands located within a cholesterol domain enhance gene delivery to the target tissue","volume":"160","author":"Xu","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0265","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2217\/nnm-2016-0244","article-title":"Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells","volume":"11","author":"Xu","year":"2016","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0270","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.cbpa.2009.03.022","article-title":"Folate-targeted therapeutic and imaging agents for cancer","volume":"13","author":"Low","year":"2009","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0275","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","article-title":"Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases","volume":"41","author":"Low","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0280","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/sj.gt.3301833","article-title":"Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors","volume":"9","author":"Reddy","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0285","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.2217\/nnm.15.127","article-title":"Image-driven pharmacokinetics: nanomedicine concentration across space and time","volume":"10","author":"Brill","year":"2015","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0290","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.drudis.2016.07.006","article-title":"Injectable hydrogel-based drug delivery systems for local cancer therapy","volume":"21","author":"Norouzi","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0295","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2016.01.073","article-title":"Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy","volume":"501","author":"Rosiere","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0300","first-page":"299","article-title":"Targeted modulation of cell differentiation in distinct regions of the gastrointestinal tract via oral administration of differently PEG-PEI functionalized mesoporous silica nanoparticles","volume":"11","author":"Desai","year":"2016","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ab.2006.11.021","article-title":"Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice","volume":"361","author":"Kovar","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0310","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1007\/s11095-016-1891-7","article-title":"A multi-functional tumor theranostic nanoplatform for MRI guided photothermal-chemotherapy","volume":"33","author":"Shi","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0315","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1021\/ac303603f","article-title":"Near infrared fluorescent trypsin stabilized gold nanoclusters as surface plasmon enhanced energy transfer biosensor and in vivo cancer imaging bioprobe","volume":"85","author":"Liu","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0320","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1021\/bc2002506","article-title":"Folate receptor-targeted aggregation-enhanced near-IR emitting silica nanoprobe for one-photon in vivo and two-photon ex vivo fluorescence bioimaging","volume":"22","author":"Wang","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0325","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2012.11.038","article-title":"Cancer cell targeting and imaging with biopolymer-based nanodevices","volume":"441","author":"Hajdu","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0330","first-page":"2863","article-title":"Folate-targeted polymeric micelles loaded with ultrasmall superparamagnetic iron oxide: combined small size and high MRI sensitivity","volume":"7","author":"Hong","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0335","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/mp200511t","article-title":"Radioiodinated folic acid conjugates: evaluation of a valuable concept to improve tumor-to-background contrast","volume":"9","author":"Reber","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0340","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biomaterials.2012.09.054","article-title":"Folic acid-modified dendrimer-entrapped gold nanoparticles as nanoprobes for targeted CT imaging of human lung adencarcinoma","volume":"34","author":"Wang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0345","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1016\/j.biomaterials.2013.03.009","article-title":"Targeted CT\/MR dual mode imaging of tumors using multifunctional dendrimer-entrapped gold nanoparticles","volume":"34","author":"Chen","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0350","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.104.003723","article-title":"Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery","volume":"66","author":"Paulos","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0355","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1359-6446(00)01594-4","article-title":"Folate-mediated targeting: from diagnostics to drug and gene delivery","volume":"6","author":"Leamon","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0360","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0365","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2217\/17435889.3.5.703","article-title":"Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats","volume":"3","author":"Longmire","year":"2008","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0370","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ki.1992.7","article-title":"A high-affinity folate binding protein in proximal tubule cells of human kidney","volume":"41","author":"Holm","year":"1992","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0375","doi-asserted-by":"crossref","first-page":"6601","DOI":"10.1016\/S0021-9258(20)82184-X","article-title":"The folate-binding protein of rat kidney. Purification, properties, and cellular distribution","volume":"259","author":"Selhub","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0380","first-page":"F750","article-title":"Renal folate absorption and the kidney folate binding protein. I. Urinary clearance studies","volume":"252","author":"Selhub","year":"1987","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0385","first-page":"F757","article-title":"Renal folate absorption and the kidney folate binding protein. II. Microinfusion studies","volume":"252","author":"Selhub","year":"1987","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0390","first-page":"F484","article-title":"Renal tubular transport of folic acid and methotrexate in the monkey","volume":"242","author":"Williams","year":"1982","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0395","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/adhm.201500177","article-title":"Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases","volume":"4","author":"Lee","year":"2015","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0400","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ki.2008.128","article-title":"Proteinuria in diabetic kidney disease: a mechanistic viewpoint","volume":"74","author":"Jefferson","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0405","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1172\/JCI22562","article-title":"Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography","volume":"114","author":"Wartiovaara","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0410","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1681\/ASN.2011070711","article-title":"Folate receptor-targeted antioxidant therapy ameliorates renal ischemia-reperfusion injury","volume":"23","author":"Knight","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0415","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0305-7372(95)90010-1","article-title":"Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function","volume":"21","author":"Kintzel","year":"1995","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0420","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00001622-199507000-00003","article-title":"Strategies to prevent nephrotoxicity of anticancer drugs","volume":"7","author":"Skinner","year":"1995","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0425","doi-asserted-by":"crossref","first-page":"F543","DOI":"10.1152\/ajprenal.00112.2004","article-title":"Cisplatin-induced cell death is EGFR\/src\/ERK signaling dependent in mouse proximal tubule cells","volume":"287","author":"Arany","year":"2004","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0430","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0435","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1681\/ASN.2015010079","article-title":"Three-dimensional morphology by multiphoton microscopy with clearing in a model of cisplatin-induced CKD","volume":"27","author":"Torres","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0440","doi-asserted-by":"crossref","first-page":"F1136","DOI":"10.1152\/ajprenal.00541.2007","article-title":"Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time","volume":"296","author":"Kramer","year":"2009","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.jconrel.2017.02.023_bb0445","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jconrel.2017.02.023_bb0450","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2353\/ajpath.2010.091071","article-title":"Adriamycin nephropathy: a failure of endothelial progenitor cell-induced repair","volume":"176","author":"Yasuda","year":"2010","journal-title":"Am. J. Pathol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365917300202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:32:00Z","timestamp":1759159920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365917300202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":90,"alternative-id":["S0168365917300202"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate-mediated chemotherapy and diagnostics: An updated review and outlook","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}